NCT04483635View on ClinicalTrials.gov

PRevention of COVID-19 With Oral Vitamin D Supplemental Therapy in Essential healthCare Teams

PHASE3TerminatedINTERVENTIONAL

Enrollment

34

Participants

Timeline

Start Date

February 8, 2021

Primary Completion Date

May 4, 2021

Study Completion Date

May 25, 2021

Conditions

COVID-19

Interventions

DIETARY_SUPPLEMENT

Placebo

Weekly oral dose of placebo

DIETARY_SUPPLEMENT

Vitamin D

Weekly oral dose of Vitamin D

Trial Locations (2)

H2W 1T8

CHUM, Montreal

H3T1C5

CHU Sainte-Justine (CHUSJ), Montreal

Sponsors

Collaborators (1)

Laboratoire RIVA

All Listed Sponsors

collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Laboratoire RIVA

UNKNOWN

lead

St. Justine's Hospital

OTHER

NCT04483635 - PRevention of COVID-19 With Oral Vitamin D Supplemental Therapy in Essential healthCare Teams | Biotech Hunter | Biotech Hunter